1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Gene Therapy For Heart Failure Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Gene Modification 1.2.3 Gene Replacement 1.2.4 Others 1.3 Market by Application 1.3.1 Global Gene Therapy For Heart Failure Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital 1.3.3 Laboratory 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Gene Therapy For Heart Failure Market Perspective (2017-2028) 2.2 Gene Therapy For Heart Failure Growth Trends by Region 2.2.1 Gene Therapy For Heart Failure Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Gene Therapy For Heart Failure Historic Market Size by Region (2017-2022) 2.2.3 Gene Therapy For Heart Failure Forecasted Market Size by Region (2023-2028) 2.3 Gene Therapy For Heart Failure Market Dynamics 2.3.1 Gene Therapy For Heart Failure Industry Trends 2.3.2 Gene Therapy For Heart Failure Market Drivers 2.3.3 Gene Therapy For Heart Failure Market Challenges 2.3.4 Gene Therapy For Heart Failure Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gene Therapy For Heart Failure Players by Revenue 3.1.1 Global Top Gene Therapy For Heart Failure Players by Revenue (2017-2022) 3.1.2 Global Gene Therapy For Heart Failure Revenue Market Share by Players (2017-2022) 3.2 Global Gene Therapy For Heart Failure Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Gene Therapy For Heart Failure Revenue 3.4 Global Gene Therapy For Heart Failure Market Concentration Ratio 3.4.1 Global Gene Therapy For Heart Failure Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy For Heart Failure Revenue in 2021 3.5 Gene Therapy For Heart Failure Key Players Head office and Area Served 3.6 Key Players Gene Therapy For Heart Failure Product Solution and Service 3.7 Date of Enter into Gene Therapy For Heart Failure Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Gene Therapy For Heart Failure Breakdown Data by Type 4.1 Global Gene Therapy For Heart Failure Historic Market Size by Type (2017-2022) 4.2 Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2023-2028) 5 Gene Therapy For Heart Failure Breakdown Data by Application 5.1 Global Gene Therapy For Heart Failure Historic Market Size by Application (2017-2022) 5.2 Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Gene Therapy For Heart Failure Market Size (2017-2028) 6.2 North America Gene Therapy For Heart Failure Market Size by Country (2017-2022) 6.3 North America Gene Therapy For Heart Failure Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Gene Therapy For Heart Failure Market Size (2017-2028) 7.2 Europe Gene Therapy For Heart Failure Market Size by Country (2017-2022) 7.3 Europe Gene Therapy For Heart Failure Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Gene Therapy For Heart Failure Market Size (2017-2028) 8.2 Asia-Pacific Gene Therapy For Heart Failure Market Size by Country (2017-2022) 8.3 Asia-Pacific Gene Therapy For Heart Failure Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Gene Therapy For Heart Failure Market Size (2017-2028) 9.2 Latin America Gene Therapy For Heart Failure Market Size by Country (2017-2022) 9.3 Latin America Gene Therapy For Heart Failure Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Gene Therapy For Heart Failure Market Size (2017-2028) 10.2 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2017-2022) 10.3 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Askbio 11.1.1 Askbio Company Detail 11.1.2 Askbio Business Overview 11.1.3 Askbio Gene Therapy For Heart Failure Introduction 11.1.4 Askbio Revenue in Gene Therapy For Heart Failure Business (2017-2022) 11.1.5 Askbio Recent Development 11.2 RENOVACORINC 11.2.1 RENOVACORINC Company Detail 11.2.2 RENOVACORINC Business Overview 11.2.3 RENOVACORINC Gene Therapy For Heart Failure Introduction 11.2.4 RENOVACORINC Revenue in Gene Therapy For Heart Failure Business (2017-2022) 11.2.5 RENOVACORINC Recent Development 11.3 Uniqure 11.3.1 Uniqure Company Detail 11.3.2 Uniqure Business Overview 11.3.3 Uniqure Gene Therapy For Heart Failure Introduction 11.3.4 Uniqure Revenue in Gene Therapy For Heart Failure Business (2017-2022) 11.3.5 Uniqure Recent Development 11.4 DINAQOR 11.4.1 DINAQOR Company Detail 11.4.2 DINAQOR Business Overview 11.4.3 DINAQOR Gene Therapy For Heart Failure Introduction 11.4.4 DINAQOR Revenue in Gene Therapy For Heart Failure Business (2017-2022) 11.4.5 DINAQOR Recent Development 11.5 PRECIGEN 11.5.1 PRECIGEN Company Detail 11.5.2 PRECIGEN Business Overview 11.5.3 PRECIGEN Gene Therapy For Heart Failure Introduction 11.5.4 PRECIGEN Revenue in Gene Therapy For Heart Failure Business (2017-2022) 11.5.5 PRECIGEN Recent Development 11.6 Heartseed 11.6.1 Heartseed Company Detail 11.6.2 Heartseed Business Overview 11.6.3 Heartseed Gene Therapy For Heart Failure Introduction 11.6.4 Heartseed Revenue in Gene Therapy For Heart Failure Business (2017-2022) 11.6.5 Heartseed Recent Development 11.7 Cardior 11.7.1 Cardior Company Detail 11.7.2 Cardior Business Overview 11.7.3 Cardior Gene Therapy For Heart Failure Introduction 11.7.4 Cardior Revenue in Gene Therapy For Heart Failure Business (2017-2022) 11.7.5 Cardior Recent Development 11.8 NOVARTIS 11.8.1 NOVARTIS Company Detail 11.8.2 NOVARTIS Business Overview 11.8.3 NOVARTIS Gene Therapy For Heart Failure Introduction 11.8.4 NOVARTIS Revenue in Gene Therapy For Heart Failure Business (2017-2022) 11.8.5 NOVARTIS Recent Development 11.9 Blue Rock 11.9.1 Blue Rock Company Detail 11.9.2 Blue Rock Business Overview 11.9.3 Blue Rock Gene Therapy For Heart Failure Introduction 11.9.4 Blue Rock Revenue in Gene Therapy For Heart Failure Business (2017-2022) 11.9.5 Blue Rock Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Gene Therapy For Heart Failure Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Gene Modification Table 3. Key Players of Gene Replacement Table 4. Key Players of Others Table 5. Global Gene Therapy For Heart Failure Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Gene Therapy For Heart Failure Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Gene Therapy For Heart Failure Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Gene Therapy For Heart Failure Market Share by Region (2017-2022) Table 9. Global Gene Therapy For Heart Failure Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Gene Therapy For Heart Failure Market Share by Region (2023-2028) Table 11. Gene Therapy For Heart Failure Market Trends Table 12. Gene Therapy For Heart Failure Market Drivers Table 13. Gene Therapy For Heart Failure Market Challenges Table 14. Gene Therapy For Heart Failure Market Restraints Table 15. Global Gene Therapy For Heart Failure Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Gene Therapy For Heart Failure Market Share by Players (2017-2022) Table 17. Global Top Gene Therapy For Heart Failure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Heart Failure as of 2021) Table 18. Ranking of Global Top Gene Therapy For Heart Failure Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Gene Therapy For Heart Failure Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Gene Therapy For Heart Failure Product Solution and Service Table 22. Date of Enter into Gene Therapy For Heart Failure Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Gene Therapy For Heart Failure Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2017-2022) Table 26. Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2023-2028) Table 28. Global Gene Therapy For Heart Failure Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2017-2022) Table 30. Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2023-2028) Table 32. North America Gene Therapy For Heart Failure Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Gene Therapy For Heart Failure Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Gene Therapy For Heart Failure Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Gene Therapy For Heart Failure Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Gene Therapy For Heart Failure Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Gene Therapy For Heart Failure Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2023-2028) & (US$ Million) Table 42. Askbio Company Detail Table 43. Askbio Business Overview Table 44. Askbio Gene Therapy For Heart Failure Product Table 45. Askbio Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million) Table 46. Askbio Recent Development Table 47. RENOVACORINC Company Detail Table 48. RENOVACORINC Business Overview Table 49. RENOVACORINC Gene Therapy For Heart Failure Product Table 50. RENOVACORINC Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million) Table 51. RENOVACORINC Recent Development Table 52. Uniqure Company Detail Table 53. Uniqure Business Overview Table 54. Uniqure Gene Therapy For Heart Failure Product Table 55. Uniqure Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million) Table 56. Uniqure Recent Development Table 57. DINAQOR Company Detail Table 58. DINAQOR Business Overview Table 59. DINAQOR Gene Therapy For Heart Failure Product Table 60. DINAQOR Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million) Table 61. DINAQOR Recent Development Table 62. PRECIGEN Company Detail Table 63. PRECIGEN Business Overview Table 64. PRECIGEN Gene Therapy For Heart Failure Product Table 65. PRECIGEN Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million) Table 66. PRECIGEN Recent Development Table 67. Heartseed Company Detail Table 68. Heartseed Business Overview Table 69. Heartseed Gene Therapy For Heart Failure Product Table 70. Heartseed Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million) Table 71. Heartseed Recent Development Table 72. Cardior Company Detail Table 73. Cardior Business Overview Table 74. Cardior Gene Therapy For Heart Failure Product Table 75. Cardior Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million) Table 76. Cardior Recent Development Table 77. NOVARTIS Company Detail Table 78. NOVARTIS Business Overview Table 79. NOVARTIS Gene Therapy For Heart Failure Product Table 80. NOVARTIS Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million) Table 81. NOVARTIS Recent Development Table 82. Blue Rock Company Detail Table 83. Blue Rock Business Overview Table 84. Blue Rock Gene Therapy For Heart Failure Product Table 85. Blue Rock Revenue in Gene Therapy For Heart Failure Business (2017-2022) & (US$ Million) Table 86. Blue Rock Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Gene Therapy For Heart Failure Market Share by Type: 2021 VS 2028 Figure 2. Gene Modification Features Figure 3. Gene Replacement Features Figure 4. Others Features Figure 5. Global Gene Therapy For Heart Failure Market Share by Application in 2021 & 2028 Figure 6. Hospital Case Studies Figure 7. Laboratory Case Studies Figure 8. Others Case Studies Figure 9. Gene Therapy For Heart Failure Report Years Considered Figure 10. Global Gene Therapy For Heart Failure Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Gene Therapy For Heart Failure Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Gene Therapy For Heart Failure Market Share by Region: 2021 VS 2028 Figure 13. Global Gene Therapy For Heart Failure Market Share by Players in 2021 Figure 14. Global Top Gene Therapy For Heart Failure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy For Heart Failure as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy For Heart Failure Revenue in 2021 Figure 16. North America Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Gene Therapy For Heart Failure Market Share by Country (2017-2028) Figure 18. United States Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Gene Therapy For Heart Failure Market Share by Country (2017-2028) Figure 22. Germany Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Gene Therapy For Heart Failure Market Share by Region (2017-2028) Figure 30. China Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Gene Therapy For Heart Failure Market Share by Country (2017-2028) Figure 38. Mexico Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Gene Therapy For Heart Failure Market Share by Country (2017-2028) Figure 42. Turkey Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Gene Therapy For Heart Failure Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Askbio Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022) Figure 45. RENOVACORINC Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022) Figure 46. Uniqure Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022) Figure 47. DINAQOR Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022) Figure 48. PRECIGEN Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022) Figure 49. Heartseed Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022) Figure 50. Cardior Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022) Figure 51. NOVARTIS Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022) Figure 52. Blue Rock Revenue Growth Rate in Gene Therapy For Heart Failure Business (2017-2022) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

Askbio RENOVACORINC Uniqure DINAQOR PRECIGEN Heartseed Cardior NOVARTIS Blue Rock